Solani Therapeutics Ltd develops new solutions for animal therapeutics by combining already marketed active pharmaceutical ingredients with novel formulations and delivery methods. Solani's market oriented approach relies on building project specific networks with best veterinary and technology expertise. Our aim is to pan for commercially most attractive, low-risk product ideas that help treatments of companion animals both in veterinary clinics and at home. Solani's first project entered the preclinical phase in August 2014.